Rappuoli R - Search Results

1

Progress towards the development of new vaccines against whooping cough.

Rappuoli R, Podda A, Pizza M, Covacci A, Bartoloni A, de Magistris MT, Nencioni L. Rappuoli R, et al. Vaccine. 1992;10(14):1027-32. doi: 10.1016/0264-410x(92)90112-w. Vaccine. 1992. PMID: 1471424 Review.

2

Interaction of the pertussis toxin peptide containing residues 30-42 with DR1 and the T-cell receptors of 12 human T-cell clones.

De Magistris MT, Di Tommaso A, Domenighini M, Censini S, Tagliabue A, Oksenberg JR, Steinman L, Judd AK, O'Sullivan D, Rappuoli R. De Magistris MT, et al. Among authors: rappuoli r. Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2990-4. doi: 10.1073/pnas.89.7.2990. Proc Natl Acad Sci U S A. 1992. PMID: 1313575 Free PMC article.

3

Towards third-generation whooping cough vaccines.

Rappuoli R, Pizza M, Podda A, De Magistris MT, Nencioni L. Rappuoli R, et al. Trends Biotechnol. 1991 Jul;9(7):232-8. doi: 10.1016/0167-7799(91)90076-t. Trends Biotechnol. 1991. PMID: 1370047 Review.

4

Recombinant acellular pertussis vaccine--from the laboratory to the clinic: improving the quality of the immune response.

Rappuoli R, Pizza M, Covacci A, Bartoloni A, Nencioni L, Podda A, De Magistris MT. Rappuoli R, et al. FEMS Microbiol Immunol. 1992 Oct;5(4):161-70. doi: 10.1111/j.1574-6968.1992.tb05898.x. FEMS Microbiol Immunol. 1992. PMID: 1384602

5

Immunity to Haemophilus influenzae type b on sample population from central Italy.

Sansoni A, Rappuoli R, Viti S, Costantino P, Fanti O, Cellesi C. Sansoni A, et al. Among authors: rappuoli r. Vaccine. 1992;10(9):627-30. doi: 10.1016/0264-410x(92)90445-p. Vaccine. 1992. PMID: 1502841

6

Development and phase 1 clinical testing of a conjugate vaccine against meningococcus A and C.

Costantino P, Viti S, Podda A, Velmonte MA, Nencioni L, Rappuoli R. Costantino P, et al. Among authors: rappuoli r. Vaccine. 1992;10(10):691-8. doi: 10.1016/0264-410x(92)90091-w. Vaccine. 1992. PMID: 1523880 Clinical Trial.

7

Cellular pertussis vaccine containing a Bordetella pertussis strain that produces a nontoxic pertussis toxin molecule.

Marsili I, Pizza M, Giovannoni F, Volpini G, Bartalini M, Olivieri R, Rappuoli R, Nencioni L. Marsili I, et al. Among authors: rappuoli r. Infect Immun. 1992 Mar;60(3):1150-5. doi: 10.1128/iai.60.3.1150-1155.1992. Infect Immun. 1992. PMID: 1541530 Free PMC article.

8

Acellular pertussis vaccine composed of genetically inactivated pertussis toxin: safety and immunogenicity in 12- to 24- and 2- to 4-month-old children.

Podda A, De Luca EC, Titone L, Casadei AM, Cascio A, Peppoloni S, Volpini G, Marsili I, Nencioni L, Rappuoli R. Podda A, et al. Among authors: rappuoli r. J Pediatr. 1992 May;120(5):680-5. doi: 10.1016/s0022-3476(05)80227-6. J Pediatr. 1992. PMID: 1578301

9

Development and clinical testing of an acellular pertussis vaccine containing genetically detoxified pertussis toxin.

Rappuoli R, Pizza M, De Magistris MT, Podda A, Bugnoli M, Manetti R, Nencioni L. Rappuoli R, et al. Immunobiology. 1992 Feb;184(2-3):230-9. doi: 10.1016/S0171-2985(11)80477-8. Immunobiology. 1992. PMID: 1587545 Review.

10

Human T cell immunity against Bordetella pertussis analyzed at clonal level.

De Magistris MT, Rappuoli R, Tagliabue A. De Magistris MT, et al. Among authors: rappuoli r. Ann Ist Super Sanita. 1991;27(1):33-6. Ann Ist Super Sanita. 1991. PMID: 1683526

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

818 results

Search Page

Filters